Healthcare >> Analyst Interviews >> May 6, 2002

Canadian Biotechnology Stocks: Brian Bapty – Raymond James Ltd

BRIAN BAPTY joined the healthcare team at Raymond James Ltd. in January 2000. Prior to joining Raymond James, Dr. Bapty was the Biotechnology Analyst at Goepel McDermid. He has been an independent bio/medical technology consultant and held positions as officer to several publicly-traded companies. Dr. Bapty was ranked sixth overall by Brendan Woods after less than one year as an Analyst ' first in Credibility of Research, third in Quality of Written Reports, and was designated by Brendan Woods as a 'rising star'. He has a BSc in Cell and Developmental Biology and a PhD in Experimental Medicine -Nephrology from the University of British Columbia. Profile
TWST: Brian, what do you include in your coverage at Raymond


Dr. Bapty: From top to bottom, health care and biotech in Canada

is the general coverage. In terms of integrated health